Reassembly of Nucleosomes at the MLH1 Promoter Initiates Resilencing Following Decitabine Exposure |
| |
| Authors: | Luke B Hesson Vibha Patil Mathew A Sloane Andrea C Nunez Jia Liu John E Pimanda Robyn L Ward |
| |
| Institution: | Adult Cancer Program, Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia;University of Washington, United States of America |
| |
| Abstract: | Hypomethylating agents reactivate tumor suppressor genes that are epigenetically silenced in cancer. Inevitably these genes are resilenced, leading to drug resistance. Using the MLH1 tumor suppressor gene as a model, we showed that decitabine-induced re-expression was dependent upon demethylation and eviction of promoter nucleosomes. Following decitabine withdrawal, MLH1 was rapidly resilenced despite persistent promoter demethylation. Single molecule analysis at multiple time points showed that gene resilencing was initiated by nucleosome reassembly on demethylated DNA and only then was followed by remethylation and stable silencing. Taken together, these data establish the importance of nucleosome positioning in mediating resilencing of drug-induced gene reactivation and suggest a role for therapeutic targeting of nucleosome assembly as a mechanism to overcome drug resistance. |
| |
| Keywords: | |
|
|
